Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: Short- and long-term follow-up

Italian Journal of Gastroenterology

Volumn 28, Issue 6, 1996, Pages 324-331

  Zavaglia, C ^a   Bottelli, R ^a   Bellati, G ^a   Asti, L ^a   Mondazzi, L ^a   Iamoni, G ^a   Zanetti, A ^c   Tanzi, E ^c   Fesce, E ^a   Gelosa, F ^a   Maggi, G ^b   Ideo, G ^a,d  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Ospedale FBF   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Chronic hepatitis B; Corticosteroids; Interferon

Indexed keywords

ALPHAN1 INTERFERON; ANTIVIRUS AGENT; CORTICOSTEROID; DEFLAZACORT; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CHILL; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HEPATITIS B; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; IRRITABILITY; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER HISTOLOGY; MALE; MYALGIA; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SERODIAGNOSIS; VIRUS REPLICATION; WEIGHT REDUCTION;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; BIOPSY; CHRONIC DISEASE; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; INTERFERON-ALPHA; MALE; PREGNENEDIONES; RADIOIMMUNOASSAY; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 10144262545     PISSN: 03920623     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Aldershvile J, Dietrichson O, Skinhoj B, Kryger P, Mathiesen LR, Cristoffersen P, et al. Chronic persistent hepatitis: serological classification and meaning of the hepatitis B e system. Hepatology 1982; 2: 243-6.
2. Fattovich G, Brollo L, Alberti A, Giustina G, Pontisso P, Realdi G, et al. Chronic persistent hepatitis type B can be a progressive disease when associated with sustained virus replication. J Hepatol 1990; 11: 29-33.
3. Alexander GJM, Brahm J, Fagan EA, Smith HM, Daniels HM, Eddleston ALWF, et al. Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet 1987; 2: 66-9.
4. Scully LJ, Shein R, Karayiannis P, McDonald JA, Thomas HC. Lymphoblastoid interferon therapy of chronic HBV infection. A comparison of 12 vs 24 weeks of thrice weekly treatment. J Hepatol 1987; 5: 51-8.
5. Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med 1991; 114: 629-34.
6. Carreno V, Castillo I, Molina J, Porres JC, Bartolomé J. Long-term follow-up of hepatitis B chronic carriers who responded to interferon therapy. J Hepatol 1992; 15: 102-6.
7. Lok ASF, Chung H-T, Liu VWS, Ma OCK. Long-term follow-up of chronic hepatitis B patients treated with interferon alfa. Gastroenterology 1993; 105: 1833-8.
8. Lam KCL, Lai CL, Trepo C, Wu PC. Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 1981; 304: 380-6.
9. European Association for the Study of the Liver. Steroids in chronic B-hepatitis. A randomized, double-blind, multinational trial on the effect of low-dose, long-term treatment on survival. Liver 1986; 6: 227-32.
10. Scullard GH, Smith Cl, Merigan TC, Robinson WS, Gregory PB. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 1981; 81: 987-91.
11. Rakela J, Redeker AG, Weliky B. Effect of short-term prednisone therapy on aminotransferase levels and hepatitis B virus markers in chronic type B hepatitis. Gastroenterology 1983; 84: 956-60.
12. Nair PV, Tong MJ, Stevenson D, Roskamp D, Boone C. A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B. Hepatology 1986; 6: 1319-24.
13. Yokosuka O, Omata M, Imazeki F, Hirota K, Mon J, Uchiumi K, et al. Combination of short-term prednisolone and adenine arabinoside in the treatment of chronic hepatitis B. A controlled study. Gastroenterology 1985; 89: 246-51.
14. Omata M, Imazeki F, Yokosuka O, Ito Y, Uchiumi K, Mori J, et al. Recombinant leukocyte A interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance and biologic effects. Gastroenterology 1985; 88: 870-80.
15. Perrillo RP, Regenstein FG. Corticosteroid therapy for chronic active hepatitis B: is a little too much? Hepatology 1986; 6: 1416-8.
16. Sagnelli E, Manzillo G, Maio G, Felaco GM, Izzo CM, Pasquale G, et al. Serum levels of hepatitis B surface and core antigens during immunosuppressive treatment of HBsAg-positive chronic active hepatitis. Lancet 1980; 2: 395-7.
17. Perrillo RP. Interferon in the management of chronic hepatitis B. Dig Dis Sci 1993; 38: 577-93.
18. Pignatelli M, Waters J, Brown D, Lever A, Iwarson S, Schaff Z, et al. HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection. Hepatology 1986; 6: 349-53.
19. Kuhns MC, McNamara AL, Cabal CM, Decker RH, Thiers V, Brechot C, et al. A new assay for the quantitative detection of hepatitis B viral DNA in human serum. In: Viral Hepatitis and Liver Disease. Zuckerman AJ, Ed. New York: Alan R. Liss, Inc., 1988: 258-62.
20. Brunetto MR, Cerenzia MT, Oliven F, Piantino P, Randone A, Calvo P-L, et al. Monitoring the natural course and response to therapy of chronic hepatitis B with an automated semi-quantitative assay for IgM anti-HBc. J Hepatol 1993; 19: 431-6.
21. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991; 13: 372-4.
22. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294-8.
23. Bonino F, Hoyer B, Nelson J, Engle R, Verme G, Gerin J. Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology 1981; 1: 386-91.
24. Hadziyannis SJ, Lieberman HM, Karvountzis GG, Shafritz DA. Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg vs antiHBe positive carriers of hepatitis B virus. Hepatology 1983; 3: 656-62.
25. Hoofnagle JH, Peters M, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, et al. Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B. Gastroenterology 1988; 95: 1318-25.
26. Saracco G, Mazzella G, Rosina F, Cancellieri C, Lattore V, Raise E, et al. A controlled trial of human lymphoblastoid interferon in chronic hepatitis B in Italy. Hepatology 1989; 10: 336-41.
27. Muller R, Baumgarten R, Markus R, Schulz M, Wittenberg H, Hintsche-Kilger B, et al. Treatment of chronic hepatitis B with interferon alfa-2b. J Hepatol 1990; 11: S137-40.
28. Perrillo RP, Schiff ER, Davis GL, Bodenheimer HC Jr, Lindsay K, Payne J, Dienstag JL, O'Brien C, Tamburro C, Jacobson IM, Sampliner R, Feit D, Lefkowitch J, Kuhns M, Meschievitz C, Sanghvi B, Albrecht J, Gibas A, and the Hepatitis Interventional Therapy Group. A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. N Engl J Med 1990; 323: 295-301.
29. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med 1993; 119: 312-23.
30. Laskus T, Cianciara J, Loch T, Slusarczyk J. Short-term corticosteroid therapy for chronic active hepatitis B. Digestion 1990; 47: 115-20.
31. Zarski J-P, Causse X, Cohard M, Cougnard J, Trepo C and a French Multicenter Group. A randomized, con-trolled trial of Interferon alfa-2b alone and simultaneous prednisone for the treatment of chronic hepatitis B. J Hepatol 1994; 20: 735-41.
32. Lok ASF, Wu PC, Lai CL, Lau JYN, Leung EKY, Wong LSK, et al. A controlled trial of Interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology 1992; 102: 2091 -7.
33. Fevery J, Elewaut A, Michielsen P, Nevens F, Van Eyken P, Adler M, et al. Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study. J Hepatol 1990; 11: 8108-5112.
34. Perez V, Tanno H, Villamil F, Fay O. Recombinant interferon alfa-2b following prednisone withdrawal in the treatment of chronic type B hepatitis. J Hepatol 1990; 11: S113-7.
35. Hoofnagle JH, Davis GL, Pappas SC, Hanson RG, Peters M, Avigan MI, et al. A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1986; 104: 12-7.
36. Laskus T, Slusarczyk J, Cianciara J, Loch T. Exacerbation of chronic active hepatitis type B after short-term corticosteroid therapy resulting in fatal liver failure. Am J Gastroenterol 1990; 85: 1414-7.
37. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-5.
38. Perrillo RP, Brunt EM. Hepatic histology and immunohistochemical changes in chronic hepatitis B after prolonged clearance of hepatitis B e antigen and hepatitis B surface antigen. Ann Intern Med 1991; 115: 113-5.
39. Brook MG, Petrovic L, McDonald JA, Scheuer PJ, Thomas HC. Histological improvement after anti-viral treatment for chronic hepatitis B virus infection. J Hepatol 1989; 8: 218-25.
40. Tinè F, Liberati A, Craxì A, Almasio P, Pagliaro L. Interferon treatment in patients with chronic hepatitis B: a meta-analysis of the published literature. J Hepatol 1993; 18: 154-62.